We are looking for an Associate Professor in molecular therapy development in the field of inherited metabolic diseases! Embedded in the Emma Center for Personalized Medicine, in a joint effort between depts Human Genetics and Genetic Metabolic Diseases nature.com/naturecareers/…

Our #HorizonEurope #MSCA network MIRACLE is recruiting 11 #PhD candidates in 7 partner labs to study the inflammatory regulation of cardiometabolic diseases. 🇳🇱🇫🇷🇩🇪🇫🇮🇨🇭🇮🇹 Apply now at miracle-dn.eu Thanks for sharing this with your network!

AI is here today and to stay in biomedical science and the hospital #FCVB2025

Amazing job by our colleague Clarissa Becher with her presentation at #FCVB2024 ❤️‍🩹 ❗️ BMP9 attenuates IL-33 signaling and prevents endothelial-to-mesenchymal transition in pulmonary arterial hypertension. CVCB Leiden #ESCbasicscience European Society of Cardiology

Anke Smits talking on Epicardial inflammation in obesity and diabetes Speaker: Anke Smits (Leiden University Medical Center) #FCVB2024 #ESCardio Carolina Balbi Monika Gladka Carol Ann Remme Anke Smits

Joost Klein disqualified. Disproportionate and disgraceful decision EBU. Long live the future of Eurovision - not. With this EBU anything can happen in future

In een publicatie in Molecular Cancer delen onderzoekers opmerkelijke bevindingen over het kankermedicijn aclarubicine. Dit is een effectief geneesmiddel voor bloedkanker dat in China en Japan wordt toegepast, maar niet (meer) in Nederland. Lees meer⬇️ bit.ly/4ctOMg1

Sotatercept has recently emerged as a promising therapy for pulmonary hypertension. Is it the only approach for #PAH based on TGF-beta soluble molecules? Read more in Clarissa Becher review in JACC Journals. CINN CSIC Asturias CVCB Leiden Frances Handokodeman doi.org/10.1016/j.jacb…

Great presentation by Clarissa Becher during the 8th DCVA translational cardiovascular research symposium

Marius Wits clearly explained why his new method to measure BMP TGFbeta activity is the way to understand patient specifiek responses in #PAH

Mats Vervoorn presented how close we did get to the moon in the last 5 years for ex vivo cardiac perfusion for cardiac regeneration @RegMed_XB CVCB Leiden LUMC Leiden #repairingtheheart #regeneration

Tamara Borsboom did a great job presented her thesis project showing the impact of endothelial deletion of PDGFra during embryonic development on the development of the great arteries. #TGA #congenitalheartdisease #EndMT CVCB Leiden LUMC Leiden Stichting Hartekind #outreachconsortium

Day 2 of IVBM 2024 started with a great keynote by Stainier Lab talking about genetic compensation

Marius proudly presented his recent work to develop a BMP activity assay IVBM 2024 CVCB Leiden #PAH #TGFbeta #BMP

Clarissa proudly presented her recent findings how PAH endothelial cells respond to BMP9 IVBM 2024 Clarissa Becher #PAH #TGFbeta #BMP CVCB Leiden

GLP-1 receptor agonists, which are effective for weight loss, can cause substantial muscle loss. A Comment in The Lancet Diabetes & Endocrinology discusses the effects of GLP-1 receptor agonists on skeletal muscle mass: hubs.li/Q02WgC490

Of the 191 lucky ERC SyG awardees, 12 (6.3%) are from the US, i.e., European taxpayer money supports research in the US. While I greatly support the openness of the ERC to promote international collaboration, I wish US funding agency were similarly supportive of European science!

Stay informed! Sign up to our mailing list to get the latest journal news and articles delivered straight to your inbox. Don't miss out: vb.bioscientifica.com/page/alerts

Why should you submit to Vascular Biology? - Open access = higher exposure - Society endorsement = credibility & community support - Free to publish - Part of a targeted scholarly conversation For more info: vb.bioscientifica.com Contact: [email protected]

Could lipocalin 2 be key to promoting blood vessel growth after ischemia? L. Zhang et al. explore how LCN2 deficiency impairs angiogenesis in vivo and in vitro. 🔗Read the full article here: doi.org/10.1530/VB-25-…